Brinzolamid og hovedmetabolitten udskilles overvejende renalt, hvorfor AZARGA er kontraindiceret hos patienter med svært nedsat nyrefunktion (se afsnit 4. 3).
Since brinzolamide and its main metabolite are excreted predominantly by the kidney, AZARGA is therefore contraindicated in patients with severe renal impairment (see section 4.3).